BioSpace News Archive

Eyecarrot Attends the 8th International Congress of Behavioural Optometry in Sydney for Official Release of Binovi

Eyecarrot Innovations Corp is pleased to announce its participation at the 8th International Congress of Behavioural Optometry (“ICBO”) held at the International Convention Centre Sydney

June 18, 2018
·
3 min read
Genetown

Planet Fitness to Present at the Jefferies 2018 Global Consumer Conference

Planet Fitness, Inc. announced that the Company will participate in the Jefferies 2018 Global Consumer Conference.

June 18, 2018
·
1 min read
Business

Aerie Pharmaceuticals Announces Appointment of William Coppola as Intellectual Property Counsel

Mr. Coppola previously held related positions at Sanofi.

June 18, 2018
·
6 min read
Deals

Quest Analytics Acquires BetterDoctor to Create First Health Plan Platform to Ensure Network Adequacy, Provider Data Accuracy and Improved Member Experience

Quest Analytics announced that it has acquired BetterDoctor

June 18, 2018
·
4 min read
Bruker Introduces ParaVision® 360 Preclinical Imaging Software and AVANCE® NEO Systems with Advanced Multi-Receive Architecture for MRI

At the International Society of Magnetic Resonance in Medicine Conference (www.ismrm.org), Bruker announced the launch of the next version of its preclinical imaging software, ParaVision 360.

June 18, 2018
·
3 min read
Bio NC

Agile Sciences-Breaking the Cycle of Antibiotic Resistance

Agile Sciences has developed a proprietary portfolio of small molecules of the 2-Aminoamidazole family (2-AI) that breaks the cycle of antibiotic resistance through a novel mode of action.

June 18, 2018
·
1 min read
Biotech Beach

Jenny Craig Announces Integration of DNA Testing, A First For The Commercial Weight Loss Industry Nationally

Customizing nutrition plans to an individual’s genetic makeup can offer members even greater personalization for weight loss and overall wellness

June 18, 2018
·
4 min read
FDA

FDA Issues Complete Response Letter For DUOBRII™ (Halobetasol Propionate and Tazarotene) Lotion

Ortho Dermatologics announced that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding the company’s New Drug Application (NDA) for DUOBRII™1 (halobetasol propionate and tazarotene) (IDP-118) lotion in the treatment of plaque psoriasis.

June 18, 2018
·
3 min read
Policy

CAQH Achieves HITRUST CSF Certification to Further Mitigate Risk in Third Party Privacy, Security and Compliance

HITRUST Certification validates CAQH commitment to meeting key healthcare regulations and protecting sensitive private healthcare information.

June 18, 2018
·
2 min read
Deals

Translate Bio Launches Proposed Initial Public Offering

Translate Bio today announced that it has launched an initial public offering of 7,700,000 shares of its common stock.

June 18, 2018
·
3 min read